Nantahala Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Nantahala Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-139,298	Closed	-$4.96M	–	132
2023 Q4	$4.96M	Sell	139,298 -6,562	-4%	-$196K	0.3%	59
2023 Q3	$3.94M	Hold	145,860	–	–	0.34%	65
2023 Q2	$3.43M	Sell	145,860 -107,620	-42%	-$2.21M	0.33%	63
2023 Q1	$3.48M	Hold	253,480	–	–	0.27%	62
2022 Q4	$4.61M	Hold	253,480	–	–	0.3%	53
2022 Q3	$3.78M	Buy	+253,480	New	+$3.29M	0.24%	58

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Nantahala Capital Management's IDYA Position: Q1 2024 in Review

Nantahala Capital Management sold out of IDEAYA Biosciences (IDYA) in Q1 2024, closing a stake of 139,298 shares — an estimated $4.96M sold.

Nantahala Capital Management first reported a position in IDYA in Q3 2022 and held it in 6 quarters. The position peaked at $4.96M in Q4 2023. 204 funds tracked by Wall St. Rank hold IDYA as of Q1 2024.

Nantahala Capital Management reported no remaining IDEAYA Biosciences position as of Q1 2024 after selling out during the quarter.
Nantahala Capital Management sold 139,298 IDEAYA Biosciences shares in Q1 2024, an estimated $4.96M.
Nantahala Capital Management first reported a position in IDEAYA Biosciences in Q3 2022 and held it in 6 quarters.
Nantahala Capital Management's IDEAYA Biosciences position peaked at $4.96M in Q4 2023.
204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2024.

Based on Nantahala Capital Management's 13F filing for Q1 2024, filed 15 May 2024.